Caris Life Sciences has entered a commercial distribution agreement with Juniper Biologics for its tumor profiling services in the Middle East and Africa. This expansion follows the partnership with Caris to expand the same services to Southeast Asia (SEA) regions.
This exclusive partnership with Caris Life Sciences will allow Juniper Biologics to distribute this service to healthcare professionals in the Middle East and Africa. The service aims to enable more informed decisions regarding patient care. It enables oncologists to recommend highly personalized and targeted treatments, which expands care options and improves the quality of life for cancer patients.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.